Details
- Organisation Name: University of Queensland
- HHS: N/A
- Services Offered: Clinical trials site
- Website Address: www.qbi.uq.edu.au/apcn
- Contact: apcn@uq.edu.au
- Other Affiliated Research Sites: RBWH
Location
-27.4611071 - 153.0210879
Initiating study activities approval
No
Review required
2 weeks
Site Overview
The Asia-Pacific Centre for Neuromodulation (APCN) is a world leader in the integration of research, education and clinical care. APCN has strong links with international research and clinical networks on Neuromodulation technology and procedures and is a leading data hub for the Asia-Pacific region. The centre is a joint initiative of The University of Queensland at St Andrew's War Memorial Hospital.
APCN research programs aim to secure better outcomes for Deep Brain Stimulation (DBS) patients and expand the applications of DBS to treat new conditions and more patients. Through its clinical affiliations, APCN is able to rapidly translate its research into practice.
APCN plays a key role in the Asia-Pacific region in increasing the adoption and awareness of DBS and delivering leading edge training programs and placements for DBS physicians. APCN is also involved at the community level providing informative educational sessions for patients and carers.
The APCN is led by renowned researchers and clinicians, Professor Pankaj Sah and Professor Peter Silburn, co-directors of the APCN Centre, and complemented by Associate Professor Terry Coyne (neurosurgeon).
The clinical DBS team, located at the St Andrew's War Memorial Hospital (SAWMH) and led by Professor Peter Silburn and Associate Professor Terry Coyne, is at the forefront of DBS in Australia and the Asia-Pacific region. They are among the top five DBS specialist teams in the world as determined by clinical efficiency, and over the past two decades, have trained approximately 85% of the DBS practitioners in Australia. They have helped many people suffering from Parkinson's disease, Dystonia, Essential Tremor and Tourette's syndrome.
APCN research programs aim to secure better outcomes for Deep Brain Stimulation (DBS) patients and expand the applications of DBS to treat new conditions and more patients. Through its clinical affiliations, APCN is able to rapidly translate its research into practice.
APCN plays a key role in the Asia-Pacific region in increasing the adoption and awareness of DBS and delivering leading edge training programs and placements for DBS physicians. APCN is also involved at the community level providing informative educational sessions for patients and carers.
The APCN is led by renowned researchers and clinicians, Professor Pankaj Sah and Professor Peter Silburn, co-directors of the APCN Centre, and complemented by Associate Professor Terry Coyne (neurosurgeon).
The clinical DBS team, located at the St Andrew's War Memorial Hospital (SAWMH) and led by Professor Peter Silburn and Associate Professor Terry Coyne, is at the forefront of DBS in Australia and the Asia-Pacific region. They are among the top five DBS specialist teams in the world as determined by clinical efficiency, and over the past two decades, have trained approximately 85% of the DBS practitioners in Australia. They have helped many people suffering from Parkinson's disease, Dystonia, Essential Tremor and Tourette's syndrome.
HREC
- HREC Committee Name: Metro North HHS HREC A
- Meeting frequency: Monthly
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Local acting as central
- Mandate distribution of safety: No
- Meeting frequency: Monthly
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Local acting as central
- Mandate distribution of safety: No
Facility staffing and training
- Handling Investigational Product: No
- Training program for the research staff: No
- Include GCP: Yes
- Facility written sop during transportation to satellite site: N/A
- Training program for the research staff: No
- Include GCP: Yes
- Facility written sop during transportation to satellite site: N/A
Licenses to receive, store, dispense and return controlled substances
- Required Licenses or Registrations: Not Applicable
- Does the Facility have the ability to handle radio-labelled Investigational Products? No
- Does the Facility have the ability to handle radio-labelled Investigational Products? No
Equipment
- Investigational Product: N/A
- Centrifuge: No
- Refrigerated Centrifuge: No
- Centrifuge: No
- Refrigerated Centrifuge: No
Patient Records
- Record Archiving: Yes
- EMR/EHR systems: Other
- Has your Clinical Trial Site or Service been accredited? Not applicable
- Audit Type: Not Applicable
- EMR/EHR systems: Other
- Has your Clinical Trial Site or Service been accredited? Not applicable
- Audit Type: Not Applicable
Investigational product storage Capabilities
- Refrigerator (2 to 8 Degrees C): Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): No
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): No
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
Specialty Research Area
Neurological
Neurology
Neuroscience
Neurosciences
Parkinsons
Study Types
Academic
Industry
Investigator
Source Document Types
Paper and Electronic
Average time to start study (in calendar days)
Greater than 120
Support in-patient admissions
Yes
PK & PD specimens
No
Study Phase Capability
Phase I
Patient Population
Adults 18 and onwards